Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations

This cohort study evaluates stroke and major bleeding rates before and after switching from warfarin to a direct oral anticoagulant (DOAC) in patients grouped by pre-switch time-in-therapeutic range guideline thresholds.

Detalles Bibliográficos
Autores principales: Haymart, Brian, Barnes, Geoffrey D., Kong, Xiaowen, Ali, Mona, Kline-Rogers, Eva, DeCamillo, Deborah, Kaatz, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284330/
https://www.ncbi.nlm.nih.gov/pubmed/35834255
http://dx.doi.org/10.1001/jamanetworkopen.2022.22089
_version_ 1784747537092050944
author Haymart, Brian
Barnes, Geoffrey D.
Kong, Xiaowen
Ali, Mona
Kline-Rogers, Eva
DeCamillo, Deborah
Kaatz, Scott
author_facet Haymart, Brian
Barnes, Geoffrey D.
Kong, Xiaowen
Ali, Mona
Kline-Rogers, Eva
DeCamillo, Deborah
Kaatz, Scott
author_sort Haymart, Brian
collection PubMed
description This cohort study evaluates stroke and major bleeding rates before and after switching from warfarin to a direct oral anticoagulant (DOAC) in patients grouped by pre-switch time-in-therapeutic range guideline thresholds.
format Online
Article
Text
id pubmed-9284330
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-92843302022-08-01 Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations Haymart, Brian Barnes, Geoffrey D. Kong, Xiaowen Ali, Mona Kline-Rogers, Eva DeCamillo, Deborah Kaatz, Scott JAMA Netw Open Research Letter This cohort study evaluates stroke and major bleeding rates before and after switching from warfarin to a direct oral anticoagulant (DOAC) in patients grouped by pre-switch time-in-therapeutic range guideline thresholds. American Medical Association 2022-07-14 /pmc/articles/PMC9284330/ /pubmed/35834255 http://dx.doi.org/10.1001/jamanetworkopen.2022.22089 Text en Copyright 2022 Haymart B et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Haymart, Brian
Barnes, Geoffrey D.
Kong, Xiaowen
Ali, Mona
Kline-Rogers, Eva
DeCamillo, Deborah
Kaatz, Scott
Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations
title Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations
title_full Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations
title_fullStr Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations
title_full_unstemmed Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations
title_short Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations
title_sort comparison of patient outcomes before and after switching from warfarin to a direct oral anticoagulant based on time in therapeutic range guideline recommendations
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284330/
https://www.ncbi.nlm.nih.gov/pubmed/35834255
http://dx.doi.org/10.1001/jamanetworkopen.2022.22089
work_keys_str_mv AT haymartbrian comparisonofpatientoutcomesbeforeandafterswitchingfromwarfarintoadirectoralanticoagulantbasedontimeintherapeuticrangeguidelinerecommendations
AT barnesgeoffreyd comparisonofpatientoutcomesbeforeandafterswitchingfromwarfarintoadirectoralanticoagulantbasedontimeintherapeuticrangeguidelinerecommendations
AT kongxiaowen comparisonofpatientoutcomesbeforeandafterswitchingfromwarfarintoadirectoralanticoagulantbasedontimeintherapeuticrangeguidelinerecommendations
AT alimona comparisonofpatientoutcomesbeforeandafterswitchingfromwarfarintoadirectoralanticoagulantbasedontimeintherapeuticrangeguidelinerecommendations
AT klinerogerseva comparisonofpatientoutcomesbeforeandafterswitchingfromwarfarintoadirectoralanticoagulantbasedontimeintherapeuticrangeguidelinerecommendations
AT decamillodeborah comparisonofpatientoutcomesbeforeandafterswitchingfromwarfarintoadirectoralanticoagulantbasedontimeintherapeuticrangeguidelinerecommendations
AT kaatzscott comparisonofpatientoutcomesbeforeandafterswitchingfromwarfarintoadirectoralanticoagulantbasedontimeintherapeuticrangeguidelinerecommendations

Ejemplares similares